Literature DB >> 12620234

Structural basis for specific binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 peptide: a novel mode of peptide recognition.

Qin Liu1, Donna Berry, Piers Nash, Tony Pawson, C Jane McGlade, Shawn Shun-Cheng Li.   

Abstract

The SH3 domain, which normally recognizes proline-rich sequences, has the potential to bind motifs with an RxxK consensus. To explore this novel specificity, we have determined the solution structure of the Gads T cell adaptor C-terminal SH3 domain in complex with an RSTK-containing peptide, representing its physiological binding site on the SLP-76 docking protein. The SLP-76 peptide engages four distinct binding pockets on the surface of the Gads SH3 domain and upon binding adopts a unique structure characterized by a right-handed 3(10) helix at the RSTK locus, in contrast to the left-handed polyproline type II helix formed by canonical proline-rich SH3 ligands. The structure, and supporting mutagenesis and peptide binding data, reveal a novel mode of ligand recognition by SH3 domains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620234     DOI: 10.1016/s1097-2765(03)00046-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  In vivo significance of ITK-SLP-76 interaction in cytokine production.

Authors:  Juris A Grasis; David M Guimond; Nicholas R Cam; Krystal Herman; Paola Magotti; John D Lambris; Constantine D Tsoukas
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

2.  CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.

Authors:  Katarzyna Kowanetz; Koraljka Husnjak; Daniela Höller; Marcin Kowanetz; Philippe Soubeyran; Dianne Hirsch; Mirko H H Schmidt; Kresimir Pavelic; Pietro De Camilli; Paul A Randazzo; Ivan Dikic
Journal:  Mol Biol Cell       Date:  2004-04-16       Impact factor: 4.138

3.  SH2 domains recognize contextual peptide sequence information to determine selectivity.

Authors:  Bernard A Liu; Karl Jablonowski; Eshana E Shah; Brett W Engelmann; Richard B Jones; Piers D Nash
Journal:  Mol Cell Proteomics       Date:  2010-07-13       Impact factor: 5.911

Review 4.  The linker for activation of T cells (LAT) signaling hub: from signaling complexes to microclusters.

Authors:  Lakshmi Balagopalan; Robert L Kortum; Nathan P Coussens; Valarie A Barr; Lawrence E Samelson
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

Review 5.  Examining multiprotein signaling complexes from all angles.

Authors:  Jon C D Houtman; Mira Barda-Saad; Lawrence E Samelson
Journal:  FEBS J       Date:  2005-11       Impact factor: 5.542

Review 6.  Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.

Authors:  Shawn S-C Li
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

7.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

8.  Regulation of Bin1 SH3 domain binding by phosphoinositides.

Authors:  Chie Kojima; Ari Hashimoto; Izumi Yabuta; Mayumi Hirose; Shigeru Hashimoto; Yasunori Kanaho; Hideki Sumimoto; Takahisa Ikegami; Hisataka Sabe
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

9.  Assembly of the Sos1-Grb2-Gab1 ternary signaling complex is under allosteric control.

Authors:  Caleb B McDonald; Kenneth L Seldeen; Brian J Deegan; Vikas Bhat; Amjad Farooq
Journal:  Arch Biochem Biophys       Date:  2009-12-22       Impact factor: 4.013

10.  Structural basis for recognition of the T cell adaptor protein SLP-76 by the SH3 domain of phospholipase Cgamma1.

Authors:  Lu Deng; C Alejandro Velikovsky; Chittoor P Swaminathan; Sangwoo Cho; Roy A Mariuzza
Journal:  J Mol Biol       Date:  2005-09-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.